Chronic heart failure in older adults.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 3756933)

Published in Med Clin North Am on May 01, 2011

Authors

Ali Ahmed1

Author Affiliations

1: Division of Gerontology, Department of Medicine, School of Medicine, School of Public Health, Center for Aging, University of Alabama at Birmingham, 1530 3rd Avenue South, CH19-219, Birmingham, AL 35294-2041, USA. aahmed@uab.edu

Articles cited by this

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation (2005) 18.90

Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J (2008) 12.32

The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med (1997) 10.68

Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med (2008) 9.62

Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18

Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med (2010) 8.28

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet (2003) 6.55

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med (2004) 6.55

The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86

Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J (2006) 4.55

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J (2005) 4.37

The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J (2006) 4.10

Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA (2002) 4.06

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol (2007) 3.92

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89

Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med (2001) 3.80

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation (1990) 3.72

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation (2006) 3.40

Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17

Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med (2010) 3.05

Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol (2001) 2.93

Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. Int J Cardiol (2007) 2.05

A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J (2007) 2.01

Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med (2001) 1.89

Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail (1999) 1.75

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation (2010) 1.72

Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure. Ann Intern Med (2004) 1.66

Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure. J Gerontol A Biol Sci Med Sci (2005) 1.64

Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ Heart Fail (2010) 1.50

Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail (2002) 1.35

Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol (2004) 1.21

Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol (1993) 1.17

Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. J Gerontol A Biol Sci Med Sci (2007) 1.13

Usefulness of the external jugular vein examination in detecting abnormal central venous pressure in critically ill patients. Arch Intern Med (2006) 1.12

A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure. Int J Cardiol (2007) 1.11

Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study. Int J Cardiol (2009) 1.02

Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study. Int J Cardiol (2009) 1.01

A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure. Int J Cardiol (2008) 0.99

The underuse of digoxin in heart failure, and approaches to appropriate use. CMAJ (2007) 0.92

American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice. J Am Geriatr Soc (2003) 0.92

Value of orthopnea, paroxysmal nocturnal dyspnea, and medications in prospective population studies of incident heart failure. Am J Cardiol (2009) 0.91

Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount. Circ Arrhythm Electrophysiol (2009) 0.89

How far is the sternal angle from the mid-right atrium? J Gen Intern Med (2002) 0.88

Use of beta-blockers in older adults with chronic heart failure. Am J Med Sci (2004) 0.86

DEFEAT heart failure: assessment and management of heart failure in nursing homes made easy. J Am Med Dir Assoc (2008) 0.84

Clinical and hemodynamic assessment of the hepatojugular reflux. Am J Cardiol (1990) 0.79

Clinical manifestations, diagnostic assessment, and etiology of heart failure in older adults. Clin Geriatr Med (2007) 0.78

Drug treatment of systolic and of diastolic heart failure in elderly persons. J Gerontol A Biol Sci Med Sci (2005) 0.78

Best clinical practice: art, science, or both?: comment on "implantable cardiac device procedures in older patients". Arch Intern Med (2010) 0.76